1.

Characteristics of the patients and the control subjects

Variable	Control	DCM	CAD
Data are presented as Mean±SD unless indicated otherwise. DCM: Dilated cardiomyopathy. CAD: Coronary artery disease; BP: Blood pressure; TC: Serum total cholesterol; Lpa: Lipoprotein a; apoA: Apolipoprotein A; apoB: Apolipoprotein B; apoE: Apolipoprotein E; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; FBG: Fasting blood glucose; WBC: White blood cell count; hs-CRP: High sensitivity C-reactive protein; EF: Ejection fraction; cTnI: Cardiac troponin I. *P < 0.05, **P < 0.01 vs control group; #P < 0.05, ##P < 0.01 vs the other case group.
n	132	261	251
Age (year)	57.0±9.3	58.0±10.4	61.4±10.4
Gender (male/female)	79/55	151/110	136/115
Hypertension [n(%)]	33	45	79**##
Smoke [n(%)]	71	113	133
Diabetes [n(%)]	29	71	75
TC (mmol/L)	3.90±0.87	3.69±0.82*	3.76±0.91
Lpa (mg/L)	119±77.4	115±87	142±70
apo A (g/L)	0.96±0.23	0.90±0.31	0.81±0.19*
apoB (g/L)	0.90±0.23	0.80±0.17	0.86±0.25
apo E (mg/L)	48.0±34.2	45.1±22.6	41.7±16.3
TG (mmol/L)	1.65±0.79	1.99±0.72*	1.77±0.85
HDL-C (mmol/L)	1.05±0.28	0.96±0.31	0.86±0.32
LDL-C (mmol/L)	2.42±0.83	2.06±0.75*	2.38±0.89
FBG (mmol/L)	6.01±1.56	6.96±2.38*	7.09±2.41*
WBC (×109/L)	6.30±1.76	5.93±1.31	6.83±2.43
lymphocyte (×109/L)	1.73±0.55	1.81±0.58	1.61±0.60
hs-CRP (mg/L)	1.84±1.82	2.25±2.16	4.74±3.12**##
NT-proBNP (pg/mL)	101±47	1210±931**##	886±749**
EF (%)	65.3±7.71	36.5±9.50**	40.4±12.1**
cTnI (ng/mL)	0.18±0.12	0.43±0.33*	0.76±0.89**##
Disease course	0	2.53±2.07	2.46±1.81